Edition:
India

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

29.15USD
2:29am IST
Change (% chg)

$-0.35 (-1.19%)
Prev Close
$29.50
Open
$29.45
Day's High
$29.60
Day's Low
$29.00
Volume
4,223
Avg. Vol
14,388
52-wk High
$34.15
52-wk Low
$22.50

Chart for

About

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $417.55
Shares Outstanding(Mil.): 13.11
Dividend: --
Yield (%): --

Financials

BRIEF-Surmodics Receives FDA Clearance For Telemark Peripheral Support Microcatheter

* SURMODICS RECEIVES 510(K) CLEARANCE FOR TELEMARK™ CORONARY/PERIPHERAL SUPPORT MICROCATHETER FROM THE U.S. FOOD AND DRUG ADMINISTRATION

22 Jan 2018

BRIEF-Surmodics Q4 gaap earnings per share $0.03

* Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance

08 Nov 2017

BRIEF-Surmodics says received FDA 510(K) and CE mark clearance​

* Surmodics announces global approvals of .014" low-profile pta balloon dilation catheter

18 Sep 2017

BRIEF-Surmodics enters agreement with Baim Institute For Clinical Research​

* Says ‍on August 11 entered into a clinical trial services agreement with Baim Institute For Clinical Research, Inc - sec filing ​

15 Aug 2017

BRIEF-Surmodics Q3 non-GAAP earnings per share $0.09

* Surmodics reports third quarter fiscal 2017 results and updates fiscal 2017 guidance

03 Aug 2017

BRIEF-Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon

* Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon

26 Jul 2017

Competitors

Earnings vs. Estimates